NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

DGX

Quest Diagnostics, Inc

Apr 22 • 04:00PM ET

172.84

Dollar change +10.98
Percentage change 6.78	%

Healthcare • Diagnostics & Research • USA • NYSE

Peers: LH NEO EXAS OPK NTRA PMD

| Held by: VTI VOO VO SPY IVV VTV RSP XLV VOE VIG

Scroll to Statements

Index	S&P 500	P/E	22.46	EPS (ttm)	7.70	Insider Own	0.52%	Shs Outstand	111.61M	Perf Week	2.88%
Market Cap	19.29B	Forward P/E	16.43	EPS next Y	10.52	Insider Trans	-20.23%	Shs Float	111.03M	Perf Month	3.43%
Income	866.00M	PEG	2.67	EPS next Q	2.15	Inst Own	90.95%	Short Float	2.57%	Perf Quarter	13.23%
Sales	9.87B	P/S	1.95	EPS this Y	8.44%	Inst Trans	1.39%	Short Ratio	2.17	Perf Half Y	16.03%
Book/sh	61.06	P/B	2.83	EPS next Y	8.61%	ROA	5.74%	Short Interest	2.86M	Perf Year	37.27%
Cash/sh	4.92	P/C	35.14	EPS next 5Y	8.42%	ROE	13.24%	52W Range	128.38 - 178.87	Perf YTD	14.57%
Dividend Est.	3.05 (1.77%)	P/FCF	21.22	EPS past 5Y	4.04%	ROI	6.70%	52W High	-3.37%	Beta	0.54
Dividend TTM	3.05 (1.76%)	Quick Ratio	1.02	Sales past 5Y	5.68%	Gross Margin	31.87%	52W Low	34.63%	ATR (14)	5.45
Dividend Ex-Date	Apr 07, 2025	Current Ratio	1.10	EPS Y/Y TTM	2.56%	Oper. Margin	14.31%	RSI (14)	59.20	Volatility	2.85% 3.05%
Employees	56000	Debt/Eq	1.05	Sales Y/Y TTM	6.70%	Profit Margin	8.77%	Recom	2.18	Target Price	181.88
Option/Short	Yes / Yes	LT Debt/Eq	0.91	EPS Q/Q	14.58%	Payout	39.15%	Rel Volume	1.84	Prev Close	161.86
Sales Surprise	1.65%	EPS Surprise	2.02%	Sales Q/Q	14.55%	Earnings	Apr 22 BMO	Avg Volume	1.31M	Price	172.84
SMA20	4.09%	SMA50	2.38%	SMA200	9.95%	Trades		Volume	2,423,448	Change	6.78%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-02-25	Initiated	Redburn Atlantic	Buy	$195
Mar-04-25	Downgrade	Citigroup	Buy → Neutral	$185
Jan-06-25	Upgrade	Leerink Partners	Market Perform → Outperform	$169 → $174
Dec-17-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$145 → $172
Dec-10-24	Resumed	Jefferies	Buy	$175 → $185
Oct-23-24	Upgrade	Robert W. Baird	Neutral → Outperform	$157 → $182
Aug-28-24	Resumed	Evercore ISI	In-line	$165
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$145 → $165
Feb-26-24	Initiated	Leerink Partners	Market Perform	$135
Feb-07-24	Upgrade	Jefferies	Hold → Buy	$140 → $155
Jan-03-24	Initiated	Barclays	Equal Weight	$145
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy	$140 → $160
Jun-29-23	Initiated	Piper Sandler	Neutral
May-02-23	Downgrade	BofA Securities	Buy → Neutral	$166 → $148
Apr-03-23	Upgrade	Citigroup	Sell → Neutral	$125 → $142
Jan-23-23	Initiated	Evercore ISI	In-line	$159
Nov-17-22	Downgrade	Citigroup	Neutral → Sell	$145 → $125
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight	$142
Apr-04-22	Downgrade	Citigroup	Buy → Neutral	$175 → $140
Feb-23-22	Downgrade	UBS	Buy → Neutral	$160 → $139

Show Previous Ratings

Apr-22-25 04:04PM	'Safe Haven' Stock Quest Diagnostics Bounds Off 50-Day Line On Its Solid Report (Investor's Business Daily) +6.78%
01:36PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
11:39AM	Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript (Seeking Alpha)
10:34AM	Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up (Zacks)
09:07AM	Quest Diagnostics Looks Like A 'Safe Haven' After First-Quarter Beat (Investor's Business Daily)
07:55AM	Loading…
07:55AM	Quest Diagnostics (DGX) Q1 Earnings and Revenues Beat Estimates (Zacks)
06:51AM	Quest (NYSE:DGX) Beats Q1 Sales Targets (StockStory)
06:50AM	Quest Diagnostics: Q1 Earnings Snapshot (Associated Press Finance)
06:43AM	Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 (PR Newswire)
Apr-21-25 12:42PM	Quest Diagnostics Incorporated (DGX): A Bull Case Theory (Insider Monkey)
08:04AM	Quest Earnings: What To Look For From DGX (StockStory)
Apr-16-25 10:00AM	Amedisys (AMED) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-15-25 10:05AM	Quest Diagnostics price target raised to $198 from $190 at BofA (TipRanks)
10:00AM	Quest Diagnostics (DGX) Earnings Expected to Grow: Should You Buy? (Zacks)
09:28AM	Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings (Zacks)
01:27AM	Loading…
Apr-12-25 01:27AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 13 (Seeking Alpha)
Apr-11-25 06:45AM	DGX Stock Gains Following the Launch of New AD-Detect Blood Test (Zacks)
Apr-10-25 10:12AM	Quest introduces blood test to confirm amyloid brain pathology in Alzheimers (Medical Device Network)
Apr-09-25 07:53AM	Quest Diagnostics Launches New AD-Detect Blood Test to Aid in Confirming Alzheimer's Disease (PR Newswire)
Apr-05-25 11:00AM	Markets Watch Out For Core CPI With Big Banks Set To Report Earnings (Seeking Alpha)
08:00AM	T-Mobile Leads Five Stocks To Watch As Market Correction Intensifies (Investor's Business Daily)
Apr-04-25 01:43PM	8 Upcoming Dividend Increases During Volatile Times (Seeking Alpha)
Apr-03-25 04:25PM	Why IBD Stock Of The Day Quest Diagnostics Sidestepped The Sell-Off (Investor's Business Daily)
Apr-02-25 07:06AM	Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening (PR Newswire)
Apr-01-25 04:23PM	Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025 (PR Newswire)
Mar-29-25 01:55AM	Dividend Champion, Contender, And Challenger Highlights: Week Of March 30 (Seeking Alpha)
Mar-27-25 08:08AM	Is Quest Diagnostics Stock Worth Holding Onto Right Now? (Zacks)
Mar-24-25 11:06PM	Wasatch Global Value Fund Q4 2024 Commentary (SeekingAlpha)
Mar-23-25 05:58PM	Quest Diagnostics (DGX) and Google Cloud to Transform Healthcare Data with AI (InsiderMonkey)
Mar-21-25 08:19AM	DGX Stock Set to Benefit From New Google Cloud Partnership (Zacks)
12:05PM	Loading…
Mar-20-25 12:05PM	Autodesk in proxy fight, General Mills reports mixed Q3: Morning Buzz (TipRanks)
Mar-19-25 02:13PM	Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the Spotlight (Zacks)
07:52AM	Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day (PR Newswire)
Mar-18-25 09:00AM	Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI (PR Newswire)
Mar-14-25 05:08AM	Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX) (StockStory)
Feb-25-25 12:52PM	Fresenius Medical Care divests workforce by 8,200; sells Spectra assets (Medical Device Network)
Feb-24-25 11:21PM	Quest to buy Fresenius Medical Care kidney testing assets (MedTech Dive)
02:35PM	Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year (ACCESSWIRE)
08:00AM	Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics (PR Newswire)
Feb-21-25 02:15AM	GRAIL Inc (GRAL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
Feb-20-25 04:03AM	3 Reasons to Avoid DGX and 1 Stock to Buy Instead (StockStory)
Feb-19-25 04:12PM	Hims & Hers Health surges on acquisition for at-home testing (Yahoo Finance Video)
12:20PM	My Quest Story - Esmeralda Bonilla (ACCESSWIRE)
10:10AM	Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire)
Feb-13-25 04:54PM	Quest Diagnostics to Host Investor Day on March 19, 2025 (PR Newswire)
03:30PM	My Quest Story - Manny Cetina (ACCESSWIRE)
10:07AM	Grail and Quest Diagnostics to offer Galleri test to US physicians (Medical Device Network)
Feb-12-25 05:57PM	Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts (Yahoo Finance)
12:50PM	Why Grail (GRAL) Stock Is Jumping Today (Insider Monkey)
09:00AM	GRAIL and Quest Diagnostics Provide GRAIL's Galleri Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System (PR Newswire)
Feb-10-25 09:50AM	Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term (Zacks)
Feb-04-25 05:29PM	Quests (NYSE:DGX) Q4: Beats On Revenue (StockStory)
09:40AM	Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term (Zacks)
Feb-03-25 02:00PM	From College to Career - Experiencing the Building Blocks of Professional Success (ACCESSWIRE)
09:45AM	Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock (Zacks)
Jan-31-25 12:00PM	Quest Diagnostics (DGX) is a Great Momentum Stock: Should You Buy? (Zacks)
02:33AM	Quest Diagnostics Inc (DGX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
01:50AM	Q4 2024 Quest Diagnostics Inc Earnings Call (Thomson Reuters StreetEvents)
Jan-30-25 05:56PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research) +5.62%
04:14PM	Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year (PR Newswire)
04:07PM	Why Quest Diagnostics Stock Was Blasting Higher Today (Motley Fool)
07:55AM	Quest Diagnostics (DGX) Q4 Earnings and Revenues Top Estimates (Zacks)
07:04AM	Quest Diagnostics: Q4 Earnings Snapshot (Associated Press Finance)
06:45AM	Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share (PR Newswire)
Jan-28-25 07:04AM	Quest Diagnostics completes University Hospitals asset acquisition (Hospital Management)
Jan-27-25 08:56AM	Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals (PR Newswire)
Jan-24-25 09:40AM	Should Value Investors Buy Quest Diagnostics (DGX) Stock? (Zacks)
Jan-08-25 01:45PM	My Quest Story - James Murphy, Jr. (ACCESSWIRE)
08:42AM	Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer (PR Newswire)
Jan-03-25 12:10PM	Why Quest Diagnostics (DGX) is Poised to Beat Earnings Estimates Again (Zacks)
Jan-02-25 11:15AM	Everyday Hero - Kris Constantino (ACCESSWIRE)
11:00AM	Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025 (PR Newswire)
Dec-23-24 12:30PM	Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management (ACCESSWIRE)
Dec-20-24 10:31AM	Mainz Biomed partners with Quest for colorectal cancer screening test (Medical Device Network)
Dec-19-24 08:01AM	Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test (GlobeNewswire)
Dec-17-24 03:10PM	Quest Diagnostics Advances Environmental Stewardship With Renewable Energy Initiatives, Waste Reduction, and ISO 14001 Certifications in 2023 (ACCESSWIRE)
Dec-03-24 09:50AM	Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference (PR Newswire)
08:23AM	Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health (PR Newswire)
Nov-28-24 05:30AM	Why Quest Diagnostics Incorporated (DGX) Is One of the Most Undervalued Pot Stocks to Buy? (Insider Monkey)
Nov-21-24 11:30AM	Quest Diagnostics (DGX) Up 2.7% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-20-24 02:44PM	Guardant Health Stock Sees RS Rating Jump To 83 (Investor's Business Daily)
Nov-13-24 12:00PM	All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy (Zacks)
Nov-12-24 05:57PM	Quest Diagnostics Declares Quarterly Cash Dividend (PR Newswire)
Oct-25-24 09:15AM	Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out? (Zacks)
Oct-24-24 01:06AM	Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight (GuruFocus.com)
Oct-23-24 07:53AM	Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development (PR Newswire)
03:03AM	Quest Diagnostics Inc (DGX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
Oct-22-24 11:49PM	Q3 2024 Quest Diagnostics Inc Earnings Call (Thomson Reuters StreetEvents) +6.85%
05:22PM	S&P 500 Gains and Losses Today: GM Stock Pops as EVs and SUVs Drive Earnings Beat (Investopedia)
03:46PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
07:55AM	Quest Diagnostics (DGX) Beats Q3 Earnings and Revenue Estimates (Zacks)
06:51AM	Quest Diagnostics: Q3 Earnings Snapshot (Associated Press Finance)
06:45AM	Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024 (PR Newswire)
Oct-16-24 09:40AM	Are Investors Undervaluing Quest Diagnostics (DGX) Right Now? (Zacks)
Oct-15-24 10:00AM	Quest Diagnostics (DGX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:04AM	Quest Diagnostics Introduces Specimen Self-Collection for Common Genital Tract Infection Testing at Nationwide Network of Patient Service Centers (PR Newswire)
Oct-14-24 08:50AM	Quest Diagnostics Completes Acquisition of Lab Assets from OhioHealth (PR Newswire)
Sep-30-24 09:40AM	Is Quest Diagnostics (DGX) Stock Undervalued Right Now? (Zacks)
Sep-25-24 11:24AM	Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024 (PR Newswire)
Sep-24-24 09:40AM	Here's Why Quest Diagnostics (DGX) is a Strong Value Stock (Zacks)

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to physicians, hospitals, patients, and consumers. The All Other segment consists of risk assessment services and healthcare information technology. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Davis J. E.	CEO and President	Apr 02 '25	Sale	168.46	39,191	6,602,074	127,623	Apr 04 08:29 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Apr 02 '25	Sale	170.00	2,555	434,350	10,575	Apr 04 08:26 PM
Davis J. E.	Officer	Apr 02 '25	Proposed Sale	170.00	39,191	6,662,470		Apr 02 10:20 AM
KUPPUSAMY KARTHIK	Officer	Apr 02 '25	Proposed Sale	170.00	2,555	434,350		Apr 02 09:50 AM
PREVOZNIK MICHAEL E	SVP & General Counsel	Mar 17 '25	Sale	170.00	4,643	789,310	38,117	Mar 19 09:00 PM
PREVOZNIK MICHAEL E	Officer	Mar 17 '25	Proposed Sale	170.00	4,643	789,310		Mar 17 10:15 AM
Doherty Catherine T.	EVP, Regional Businesses	Mar 05 '25	Sale	174.13	5,370	935,078	68,068	Mar 07 07:23 PM
Doherty Catherine T.	EVP, Regional Businesses	Mar 04 '25	Sale	175.79	716	125,866	68,068	Mar 05 04:38 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Mar 04 '25	Sale	175.79	592	104,068	38,117	Mar 05 04:35 PM
Doherty Catherine T.	Officer	Mar 05 '25	Proposed Sale	174.13	5,370	935,078		Mar 05 09:59 AM
PREVOZNIK MICHAEL E	Officer	Mar 04 '25	Proposed Sale	175.79	592	104,068		Mar 04 10:20 AM
Doherty Catherine T.	Officer	Mar 04 '25	Proposed Sale	175.79	716	125,866		Mar 04 09:58 AM
PREVOZNIK MICHAEL E	SVP & General Counsel	Feb 27 '25	Sale	172.61	528	91,138	39,031	Feb 28 04:38 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 27 '25	Sale	172.61	824	142,231	69,178	Feb 28 04:35 PM
Doherty Catherine T.	Officer	Feb 27 '25	Proposed Sale	172.61	824	142,231		Feb 27 10:52 AM
PREVOZNIK MICHAEL E	Officer	Feb 27 '25	Proposed Sale	172.61	528	91,138		Feb 27 10:41 AM
PREVOZNIK MICHAEL E	SVP & General Counsel	Feb 20 '25	Sale	170.99	604	103,278	39,845	Feb 21 04:44 PM
Plewman Patrick	SVP for Diagnostic Services	Feb 19 '25	Sale	169.71	320	54,307	18,082	Feb 21 04:43 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 20 '25	Sale	170.99	899	153,720	70,457	Feb 21 04:41 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 19 '25	Sale	169.71	535	90,795	71,356	Feb 21 04:41 PM
PREVOZNIK MICHAEL E	Officer	Feb 20 '25	Proposed Sale	170.99	604	103,278		Feb 20 10:01 AM
Doherty Catherine T.	Officer	Feb 20 '25	Proposed Sale	170.99	899	153,720		Feb 20 09:56 AM
Gregg Vicky B	Director	Feb 05 '25	Sale	164.57	1,250	205,710	16,867	Feb 07 04:37 PM
DELANEY MARK E	SVP & Chief Commercial Officer	Feb 05 '25	Sale	164.30	403	66,214	4,624	Feb 07 04:36 PM
DELANEY MARK E	Officer	Feb 05 '25	Proposed Sale	164.30	403	66,214		Feb 05 05:06 PM
Gregg Vicky B	Director	Feb 05 '25	Proposed Sale	164.57	1,250	205,710		Feb 05 04:00 PM
DELANEY MARK E	Officer	Jan 31 '25	Proposed Sale	164.85	2,615	431,094		Jan 31 01:12 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Nov 29 '24	Option Exercise	86.63	35,146	3,044,698	73,624	Dec 02 04:43 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Nov 29 '24	Sale	163.07	35,146	5,731,302	38,478	Dec 02 04:43 PM
Doherty Catherine T.	EVP, Regional Businesses	Nov 27 '24	Option Exercise	103.57	33,103	3,428,478	101,515	Dec 02 04:41 PM
Doherty Catherine T.	EVP, Regional Businesses	Nov 27 '24	Sale	162.99	33,103	5,395,484	68,412	Dec 02 04:41 PM
PREVOZNIK MICHAEL E	Officer	Nov 29 '24	Proposed Sale	163.07	35,146	5,731,302		Nov 29 02:42 PM
Doherty Catherine T.	Officer	Nov 27 '24	Proposed Sale	162.99	33,103	5,395,484		Nov 27 04:12 PM
DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Nov 06 '24	Option Exercise	68.66	18,755	1,287,634	53,696	Nov 07 05:21 PM
DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Nov 06 '24	Sale	154.05	18,755	2,889,123	34,941	Nov 07 05:21 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Oct 28 '24	Sale	156.92	1,775	278,525	9,734	Oct 30 04:26 PM
KUPPUSAMY KARTHIK	Officer	Oct 28 '24	Proposed Sale	156.87	1,775	278,450		Oct 28 12:51 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Aug 29 '24	Option Exercise	95.80	32,551	3,118,223	71,029	Sep 03 04:30 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Aug 29 '24	Sale	154.97	32,551	5,044,516	38,478	Sep 03 04:30 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Aug 28 '24	Sale	153.26	1,990	304,990	11,459	Aug 29 04:45 PM
PREVOZNIK MICHAEL E	Officer	Aug 29 '24	Proposed Sale	154.97	32,551	5,044,516		Aug 29 01:55 PM
KUPPUSAMY KARTHIK	Officer	Aug 28 '24	Proposed Sale	153.26	1,990	304,990		Aug 28 04:49 PM
DELANEY MARK E	SVP & Chief Commercial Officer	Jul 24 '24	Sale	143.08	420	60,094	5,019	Jul 26 06:33 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Apr 29 '24	Sale	140.00	1,760	246,400	13,435	May 01 04:26 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DGX

Quest Diagnostics, Inc

Upgrade your FINVIZ experience